Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

ABSTRACT: Remarkable progress has been made in the development of new therapies for cancer, dramatically changing the landscape of treatment approaches for several malignancies and continuing to increase patient survival. Accordingly, adverse effects of cancer therapies that interfere with the continuation of best-possible care, induce life-threatening risks or lead to long-term morbidity are gaining increasing importance. Cardiovascular toxic effects of cancer therapeutics and radiation therapy are the epitome of such concerns, and proper knowledge, interpretation and management are needed and have to be placed within the context of the overall care of individual patients with cancer. Furthermore, the cardiotoxicity spectrum has broadened to include myocarditis with immune checkpoint inhibitors and

SUBMITTER: Herrmann J 

PROVIDER: S-EPMC8782611 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature